Articles

• Progress in the Genetics of Retinal Disease

  By Robert L. Avery MD; and Allen C. Ho, MD

• News Medical Update

  A summary of general medicine news that affects your patients, your practice, and you.

  By David Boyer, MD

• AAMC Guidelines for Industry Funding of CME Will Affect Ophthalmology

  The recommendations on how the academic medical community should conduct relationships with industry will have an impact on ophthalmic practice, leaders say.

  By Rachel M. Renshaw, Editor in Chief

• The Evolution of Intravitreal Triamcinolone

  By Adam Martidis, MD

• Applying for a Vitreoretinal Fellowship

  By Lawrence Y. Ho, MD; and Chirag P. Shah, MD, MPH

• Revolution and Renaissance: Part 2

  Federal legislative and regulatory policy changes have created an environment in which vitreoretinal surgery should proliferate in the ASC.

  By Michael A. Romansky, JD

• En Bloc Perfluorodissection in Vitreoretinal Surgery

  A new surgical technique for tractional retinal detachment.

  By J. Fernando Arevalo, MD, FACS

• Subfoveal CNV: From Laser Photocoagulation To Antiangiogenics

  A revolution or a chimera?

  By Stefano Piermarocchi, MD

• AMD Genetic Studies Focus on Alternative Complement Pathway

  While this pathway presents potential therapeutic targets, the details of delivery would be challenging.

  By Rando Allikmets, PhD

• Prognosticating Retinal Dystrophies in the Postgenomic Era

  Inheritance patterns of retinal diseases.

  By Xining He; Irena Tsui, MD; and Stephen H. Tsang, MD, PhD

• Leber Congenital Amaurosis: Safety, Efficacy in Early Clinical Investigation

  Three adult patients with LCA2 show signs of efficacy with no serious adverse effects.

  By Albert M. Maguire, MD

• Proactive Management for Prevention and Detection of AMD

  Involving patients in their own vision care maintenance requires education and the right tools.

  By Robert Lowenthal, MD

• The Photographic Screening for Retinopathy of Prematurity Study (Photo-ROP)

  For the Photographic Screening For Retinopathy Of Prematurity (Photo-ROP) Cooperative Group*

  By Antonio Capone Jr., MD

• Case Study: Using SD-OCT

  Looking for small changes with advanced imaging technology and pinpoint diagnosis.

  By Michael Bennett, MD

• Imaging Guides Treatment Decisions in AMD

  The role of FA and OCT to guide treatment with anti-VEGF therapy in patients with neovascular AMD.

  By Christopher B. Chambers, MD; and Tamer H. Mahmoud, MD, PhD

• Case Report: Chemoreduction and Foveal-sparing TTT for Macular Retinoblastoma

  Combined therapies allow globe retention and limited visual preservation.

  By Fariba Ghassemi, MD; and Carol L. Shields, MD

• Achieving High-performance Vitrectomy With Smaller-diameter Systems

  The next era of evolution in vitreous cutters will be driven by the quest to increase efficiency, improve safety, expand indications for use, and reduce costs.

  By Sophia Y. Fang; Joel M. Cicchella; and Mark S. Humayun, MD, PhD

• Laser Treatment Shows Promise for Diabetic Macular Edema

  A Q-switched Nd:YAG laser may allow treatment earlier and closer to the fovea than standard laser photocoagulation.

  By John Marshall, PhD, FRCPath, FRCOphth(Hon); Lucia Pelonsis, MRCOphth; Peter Hamilton, FRCS, FRCOphth; and Robin Hamilton, MBBS, MRCOphth

• Visualization in Vitrectomy Procedures

  FDA-approved injectable triamcinolone acetonide is formulated for intraocular use.

  By Seenu M. Hariprasad, MD; and David S. Dyer, MD

• 5 Questions with Neil M. Bressler, MD

  Dr. Bressler is Chief of the Retina Division, Wilmer Eye Institute, and the inagural James P. Gills Professor of Ophthalmology at Johns Hopkins University School of Medicine in Baltimore. He is also Chair of the Data and Safety Monitoring Committee for the National Eye Institute's (NEI's) intramural clinical trials, Chair of both the Submacular Surgery Trials and the Diabetic Retinopathy Clinical Research Network (DRCR.net), and is Chair of the US Food and Drug Administration's Ophthalmic Devices Panel.

  By 5 Questions with Neil M. Bressler, MD